Japanese officials have confirmed hundreds of citizens have displayed abnormal reactions after ingesting the prescription flu medication, Tamiflu.
While initial reports had the total number of citizens afflicted by the medication at 199 in May, Japan's Health, Labor and Welfare Ministry recently confirmed 211 people have now shown symptoms, the Yomiuri Shimbun said Monday.
That figure, which represents reported cases before May 31, was part of an overall total of 1,377 cases that have been recorded since the medication's 2001 release.
Included in that multi-year total are 71 people who died after taking Tamiflu, with some showing abnormal symptoms prior to their deaths and others dying suddenly.
Some experts have theorized the drug, which is produced by the Roche pharmaceutical group in Switzerland, may effectively shut down the nervous systems of those who ingest it.
The newspaper said such a shutdown could potentially result in the abnormal behavior many victims have displayed.
Copyright 2007 by United Press International
Related stories:
Study identifies toxic key to Alzheimer’s disease memory loss
Using new scientific techniques, scientists have unlocked the cascade of molecular events that lead to Alzheimer’s disease. The scientific findings published in the latest edition of Nature Medicine suggest a potential new target for the development of drug therapies to fight the irreversible and degenerative disease which affects some 29.8 million people worldwide. The total worldwide societal cost of dementia was estimated at somewhere in the region of US$315.4 billion in 2005.
Increased level of magnetic iron oxides found in Alzheimer's disease
A team of scientists, led by Professor Jon Dobson, of Keele University in Staffordshire, UK, have found, for the first time, raised levels of magnetic iron oxides in the part of the brain affected by Alzheimer's Disease (AD).
CT scans to determine heart disease in the emergency room
In the future, patients who arrive at a hospital Emergency Department complaining of chest pain may be diagnosed with a sophisticated CT scan. If the diagnosis is negative, the patient can go home—and the total time at the hospital will be much shorter than it is today.
Obese children show early signs of heart disease
Children who are obese or who are at risk for obesity show early signs of heart disease similar to obese adults with heart disease, a study by researchers at Washington University School of Medicine in St. Louis has found.
Simple eye scan opens window to multiple sclerosis
A five-minute eye exam might prove to be an inexpensive and effective way to gauge and track the debilitating neurological disease multiple sclerosis, potentially complementing costly magnetic resonance imaging to detect brain shrinkage - a characteristic of the disease’s progression.
Blood test takes step toward predicting Alzheimer's risk
One of the most distressing aspects of Alzheimer's disease is the difficulty in determining whether mild memory problems are the beginning of an inevitable mental decline. Researchers at the Stanford University School of Medicine have developed a blood test that is a step toward giving people an answer two to six years in advance of the onset of the disease.
A new century of Alzheimer's disease research
Imagine the day when a routine visit to the family doctor includes a simple blood test to predict the risk for developing Alzheimer’s disease (AD). If the test returns a worrisome result -- too many sticky brain proteins that might begin to gum up memory and thought in 10 to 15 years -- a person could be offered an aspirin-like pill to keep those proteins in check.
FDA orders stronger warnings for 4 arthritis drugs
(AP) -- The Food and Drug Administration ordered stronger warnings Thursday on four medications widely used to treat rheumatoid arthritis and other serious illnesses, saying they can raise the risk of possibly fatal fungal infections.